Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response to final rejection claim 4 of 148 patent

Re 90/008227 and 90/010562. Henneman provided a response which, IMO, clearly documents why the rejection should be retracted.

Opty

Share
New Message
Please login to post a reply